Gaining and maintaining success in today’s competitive world holds several challenges. This is why, so often, those who strive to be successful are passionate about the misfortune of others. Such is the case with Eric Lefkofsky, American businessman, and co-founder of Tempus, a technology company whose main objective is to enhance cancer treatment options for patients that face it. After watching a loved one tirelessly battle the disease, he knew he had to do something. So, in 2015, Lefkofsky and co-partner Brad Keywell began their own sort of battle with the complex disease, setting themselves out on a mission to empower and change the lives of all who had been diagnosed.
Always committed to helping others, both Lefkofsky and his wife, Elizabeth formed a charitable trust in 2006. The Lefkofsky Foundation focuses on factors such as education, human rights, and medical research. In March of 2016, the compassionate couple became proud financial supports of The Academy for Urban School, a non-profit organization that works to help strengthen relationships and the learning environment in Chicago’s Public Schools. While most of his philanthropic efforts are focused on his hometown of Chicago, Lefkofsky has made countless contributions to other organizations who support the same causes.
Feeling that too often, we take the world for granted because of our unconscious decision to only see it through our own eyes, Lefkofsky says that he remains empathetic in both business and philanthropy. It is the key to his success. Understanding that there is a possibility of someone having a problem that may actually be greater than your own. It is that empathy, that compassion that has been his main motivator, and as he says, the business itself is all about motivation.
This belief led him to where he is today. When he isn’t busy running one of his many successful businesses, you can likely find him having a one on one with local doctors and patients who are battling cancer. With their help, he truly believes we can finally have hope in cancer treatment technology.
To Learn More Click Here